The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation
about
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic ImplicationsThe cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disordersImpact of cocaine abuse on HIV pathogenesisInteractive effects of cocaine on HIV infection: implication in HIV-associated neurocognitive disorder and neuroAIDSLegal highs: staying on top of the flood of novel psychoactive substancesDrug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systemsAltered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamineNeuroimmune basis of methamphetamine toxicityRecent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiologyPharmacological treatments for methamphetamine addiction: current status and future directions.Ultra-performance liquid chromatography tandem mass spectrometry method for the determination of AZ66, a sigma receptor ligand, in rat plasma and its application to in vivo pharmacokinetics.Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages.Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems.Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress.Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Cocaine induces nuclear export and degradation of neuronal retinoid X receptor-γ via a TNF-α/JNK- mediated mechanism.Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic miceDisruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?Glutathione and redox signaling in substance abuse.Chronic oxycodone induces integrated stress response in rat brain.The tetrapartite synapse: Extracellular matrix remodeling contributes to corticoaccumbens plasticity underlying drug addictionCocaine-mediated microglial activation involves the ER stress-autophagy axis.Commentary: Methamphetamine mediates immune dysregulation in a murine model of chronic viral infection.Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's diseaseAn Ethical Exploration of Barriers to Research on Controlled Drugs.Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use.Methamphetamine-induced increases in putamen gray matter associate with inhibitory controlDevelopment of in vivo drug-induced neurotoxicity models.Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation.HIV, Tat and dopamine transmission.l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?Structural Neuroimaging in Polysubstance Users.Stakeholders' Views on Barriers to Research on Controversial Controlled Substances.HIV-associated cellular senescence: A contributor to accelerated aging.Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro.Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.Chronic treatment with Tempol during acquisition or withdrawal from CPP abolishes the expression of cocaine reward and diminishes oxidative damage.Gray matter abnormalities in cocaine versus methamphetamine-dependent patients: a neuroimaging meta-analysis.
P2860
Q21129423-BB43EC9A-77F4-4EBC-B9A2-21C3A0DD91B3Q26777952-529606C2-C0E2-4ABD-8D38-E4DB1E247343Q26779435-07AC2636-9932-45C8-A976-2EFE0B7F62B8Q26781397-5BE27073-7065-4FB1-A60A-DC4BF2A451F3Q26799231-C8EB7FE0-ACEC-4504-8E06-0953FA3D4D56Q26851241-4B610A8D-345A-47F3-97E8-4FCA67F49533Q26858946-95614B4F-9EAB-45F1-92A3-888791ED85E3Q28247084-4BF8D0C4-BE34-4D65-9900-DA9CA79095D4Q28260273-B6F517B7-2AD4-40BE-BB6E-EEBD4EEA62EDQ30240173-59E7D6C4-A198-4FD0-9D0C-B2374C5CD52CQ34005371-91EF43A3-A18B-4F3F-AB10-1A0AA23EE30DQ34404527-4C47C71A-8CAF-4F4A-98C3-D9AFDB96C856Q34438529-85C6DBD9-0376-4866-85CC-59334FD58F96Q34504916-FBFD6832-DF10-4623-8DEF-D4ED4BF1976BQ35000860-3476B22A-8E2B-4EC7-B955-13998D080678Q35007339-A2E82117-3F7C-4B16-9407-91F3FEABAE28Q35108302-2D437B6C-7219-4710-B18C-895BA8EABD55Q35559749-C214664D-AF49-4725-BC3D-D23EB21DE8C2Q35649716-867C3D62-429B-4272-BB93-72AAF8988581Q35683084-712D3F71-01E4-42E5-B6FF-E64B5E991AB3Q35777838-8F7878A1-CF2A-48AB-97D5-4004D426A434Q36108828-E28DFEC5-947F-41A8-95B4-6219A94778ABQ36111649-EC0AFC41-22B5-4243-9932-51B6319A6E77Q36396447-F1F87C2F-3898-439C-9472-C34315C37D02Q36767796-F6C2B5F6-3F36-44C8-98CE-E5B4C6D06930Q36847484-BEBFCBB3-770B-4337-9354-691BC92DC784Q37052393-0DE6FE50-3E4B-4477-991E-62A91161B942Q37079931-181C59ED-1EE5-4A31-8890-26C85EBF7048Q37164844-DBE72D6D-78B4-4D35-A99A-5537641E769BQ38259808-28826D92-7272-43AE-8BA4-DE8683D71DC9Q38555614-35FF12E3-E24D-4D37-A2A1-9A69F8D2CD40Q38812005-157E2B42-88A0-4D89-A2F7-1CFE5D50EC9DQ38951947-29709542-7D67-47BE-911D-04C2D9179541Q39017071-597128F2-A7DB-49E0-B5BC-7B228869EBBCQ39046023-BA207EBF-5385-45E3-85E6-C27F21DEC4F8Q39054700-CF9F238F-BCA9-4BCB-9413-7DF2DC4060C2Q40052643-65C4BFB0-C125-4F02-BA30-79938B0B51AEQ40262441-C0AD939E-1B7C-49BB-AF95-BC790FD6AC32Q41330757-BF1C6187-1EA1-4D5E-A6D7-B727F0A69E54Q46112792-E9174298-A402-4761-ABBE-2ECD60DC71AE
P2860
The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The effects of psychostimulant ...... function and neuroinflammation
@ast
The effects of psychostimulant ...... function and neuroinflammation
@en
The effects of psychostimulant ...... function and neuroinflammation
@en-gb
The effects of psychostimulant ...... function and neuroinflammation
@nl
type
label
The effects of psychostimulant ...... function and neuroinflammation
@ast
The effects of psychostimulant ...... function and neuroinflammation
@en
The effects of psychostimulant ...... function and neuroinflammation
@en-gb
The effects of psychostimulant ...... function and neuroinflammation
@nl
prefLabel
The effects of psychostimulant ...... function and neuroinflammation
@ast
The effects of psychostimulant ...... function and neuroinflammation
@en
The effects of psychostimulant ...... function and neuroinflammation
@en-gb
The effects of psychostimulant ...... function and neuroinflammation
@nl
P2093
P2860
P921
P356
P1476
The effects of psychostimulant ...... function and neuroinflammation
@en
P2093
Paul M Carvey
Sharanya M Kousik
T Celeste Napier
P2860
P356
10.3389/FPHAR.2012.00121
P407
P577
2012-01-01T00:00:00Z